UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

Breast cancer research : BCR, 2015-03, Vol.17 (1), p.40-40, Article 40

2015

Volltextzugriff (PDF)

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

Breast cancer research : BCR, 2009-01, Vol.11 (3), p.206-206, Article 206

2009

Volltextzugriff (PDF)

Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time

Proceedings of the National Academy of Sciences - PNAS, 2011-11, Vol.108 (47), p.18879-18886

2011

Volltextzugriff (PDF)

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

Breast cancer research : BCR, 2019-05, Vol.21 (1), p.59-59, Article 59

2019

Volltextzugriff (PDF)

Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Breast cancer research : BCR, 2023-09, Vol.25 (1), p.1-107, Article 107

2023

Volltextzugriff (PDF)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Breast cancer research : BCR, 2018-06, Vol.20 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1

Molecular pharmacology, 2011-10, Vol.80 (4), p.610-620

2011

Volltextzugriff (PDF)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Breast cancer research : BCR, 2008-01, Vol.10 (6), p.R104-R104, Article R104

2008

Volltextzugriff (PDF)

Structure−Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen

Journal of medicinal chemistry, 2010-04, Vol.53 (8), p.3273-3283

2010

Volltextzugriff (PDF)

Protective Effects of Dietary Antioxidants on Proton Total-Body Irradiation-Mediated Hematopoietic Cell and Animal Survival

Radiation research, 2009-08, Vol.172 (2), p.175-186

2009

Volltextzugriff (PDF)

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy

Breast cancer research : BCR, 2008-01, Vol.10 Suppl 4 (Suppl 4), p.S16-S16, Article S16

2008

Volltextzugriff (PDF)

The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis

Current signal transduction therapy, 2009-05, Vol.4 (2), p.88-102

2009

Volltextzugriff (PDF)

Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells

European journal of cancer (1990), 2008-08, Vol.44 (12), p.1770-1779

2008

Volltextzugriff (PDF)

RETRACTED ARTICLE: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Breast cancer research : BCR, 2012-11, Vol.14 (6), p.1-19, Article R146

2012

Volltextzugriff (PDF)

Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer

Journal of steroid biochemistry and molecular biology, 2009-03, Vol.114 (1), p.33-39

2009

Volltextzugriff (PDF)

New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis

Breast (Edinburgh), 2009-10, Vol.18 (Suppl 3), p.S10-S17

2009

Volltextzugriff (PDF)

Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)

Breast disease, 2005, Vol.24 (1), p.93-105

2005

Volltextzugriff (PDF)

The conformation of the estrogen receptor directs estrogen-induced apoptosis in breast cancer: a hypothesis

Hormone molecular biology and clinical investigation, 2011-03, Vol.5 (1), p.27-34

2011

Volltextzugriff (PDF)

Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant

Journal of steroid biochemistry and molecular biology, 2006-12, Vol.102 (1), p.128-138

2006

Volltextzugriff (PDF)

Oestrogen is bad for patients with breast cancer?

Breast cancer research : BCR, 2007-12, Vol.9 (Suppl 2), p.S22-S22, Article S22

2007

Volltextzugriff (PDF)

Abstract 2918: Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2918-2918

2016

Volltextzugriff (PDF)

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner

Breast cancer research : BCR, 2016-02, Vol.18 (1), p.25-25, Article 25

2016

Volltextzugriff (PDF)

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

BMC cancer, 2016-07, Vol.16 (1), p.487-487, Article 487

2016

Volltextzugriff (PDF)

Abstract 5488: Everolimus inhibits the proliferation of aromatase inhibitor-resistant breast cancer cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5488-5488

2014

Volltextzugriff (PDF)

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Breast cancer research : BCR, 2012-11, Vol.14 (6), p.R146-R146

2012

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(21)
Female
(20)
Breast Cancer
(18)
Oncology
(16)
Cell Line, Tumor
(12)
Apoptosis
(11)
Breast Neoplasms - Drug Therapy
(11)
Animals
(10)
Tamoxifen
(10)
Breast Neoplasms - Metabolism
(9)
Breast Neoplasms - Pathology
(8)
Drug Resistance, Neoplasm
(8)
Cell Proliferation - Drug Effects
(7)
Gene Expression Regulation, Neoplastic
(7)
Breast Neoplasms - Genetics
(6)
Mice
(6)
Tumors
(6)
Antigens, Differentiation - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

Structure−Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen

Protective Effects of Dietary Antioxidants on Proton Total-Body Irradiation-Mediated Hematopoietic Cell and Animal Survival

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy

The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis

Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells

RETRACTED ARTICLE: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer

New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis

Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)

The conformation of the estrogen receptor directs estrogen-induced apoptosis in breast cancer: a hypothesis

Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant

Oestrogen is bad for patients with breast cancer?

Abstract 2918: Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

Abstract 5488: Everolimus inhibits the proliferation of aromatase inhibitor-resistant breast cancer cells

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

Suchergebnisse filtern